Verena Gounden1, Jacqueline Jonklaas2, Steven J Soldin3. 1. Department of Laboratory Medicine, NIH Clinical Center, Bethesda, MD, USA. 2. Division of Endocrinology, Georgetown University Medical Center, Washington, DC, USA. 3. Department of Laboratory Medicine, NIH Clinical Center, Bethesda, MD, USA; Division of Endocrinology, Georgetown University Medical Center, Washington, DC, USA. Electronic address: Steven.soldin@nih.gov.
Abstract
BACKGROUND: The diagnosis of subclinical hypothyroidism is defined as the presence of an elevated thyroid stimulating hormone (TSH) with a normal free thyroxine (FT4) level. The commonly used direct analogue immunoassays for the measurement of FT4 have been shown to have poor performance at the upper and lower limits of the FT4 reference interval. PURPOSE: The purpose of this pilot study was to investigate the percentage of individuals classified as having subclinical hypothyroidism with a standard immunoassay, that actually have low free thyroid hormone levels by mass spectrometry measurements. DESIGN: Outpatient samples with elevated TSH values and normal FT4 concentrations as per standard immunoassay methods were collected. FT4 and free triiodothyronine (FT3) analyses were performed on these samples using liquid chromatography-tandem mass spectrometry (LC-MS/MS). RESULTS: Sixty five percent (n=26) of patients (n=40) had (LC-MS/MS) FT4 or FT3 or both FT4 and FT3 values below mass spectrometry reference limits. CONCLUSIONS: Our findings indicate that the direct analogue immunoassay method for FT4 measurement results in a significant proportion of patients being misclassified as having subclinical hypothyroidism. Published by Elsevier B.V.
BACKGROUND: The diagnosis of subclinical hypothyroidism is defined as the presence of an elevated thyroid stimulating hormone (TSH) with a normal freethyroxine (FT4) level. The commonly used direct analogue immunoassays for the measurement of FT4 have been shown to have poor performance at the upper and lower limits of the FT4 reference interval. PURPOSE: The purpose of this pilot study was to investigate the percentage of individuals classified as having subclinical hypothyroidism with a standard immunoassay, that actually have low free thyroid hormone levels by mass spectrometry measurements. DESIGN:Outpatient samples with elevated TSH values and normal FT4 concentrations as per standard immunoassay methods were collected. FT4 and freetriiodothyronine (FT3) analyses were performed on these samples using liquid chromatography-tandem mass spectrometry (LC-MS/MS). RESULTS: Sixty five percent (n=26) of patients (n=40) had (LC-MS/MS) FT4 or FT3 or both FT4 and FT3 values below mass spectrometry reference limits. CONCLUSIONS: Our findings indicate that the direct analogue immunoassay method for FT4 measurement results in a significant proportion of patients being misclassified as having subclinical hypothyroidism. Published by Elsevier B.V.
Entities:
Keywords:
Free thyroid hormone; Mass spectrometry; Subclinical hypothyroidism
Authors: Zubair Baloch; Pierre Carayon; Bernard Conte-Devolx; Laurence M Demers; Ulla Feldt-Rasmussen; Jean-François Henry; Virginia A LiVosli; Patricia Niccoli-Sire; Rhys John; Jean Ruf; Peter P A Smyth; Carole A Spencer; Jan R Stockigt Journal: Thyroid Date: 2003-01 Impact factor: 6.568
Authors: Joseph G Hollowell; Norman W Staehling; W Dana Flanders; W Harry Hannon; Elaine W Gunter; Carole A Spencer; Lewis E Braverman Journal: J Clin Endocrinol Metab Date: 2002-02 Impact factor: 5.958
Authors: Kerry J Welsh; Brian R Stolze; Xiaolin Yu; Trisha R Podsiadlo; Lisa S Kim; Steven J Soldin Journal: Clin Biochem Date: 2016-11-25 Impact factor: 3.281
Authors: C Ling; Q Sun; J Khang; M Felipa Lastarria; J Strong; B Stolze; X Yu; T P Parikh; M A Waldman; K Welsh; J Jonklaas; L Masika; S J Soldin Journal: Ann Thyroid Res Date: 2018-02-20